Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > The cost of the machine

<< Previous

Bullboard Posts

Next >>

Comment by Investor62on Aug 08, 2020 6:29am

68 Views

Post# 31382256

RE:RE: The cost of the machine

@letsdoit: depending on the language you are using $1B is $ 1'000'000'000 (US) or 1'000'000'000'000 (Europe) – so $ 95'000'000 is far away from both! If you want to be so cleaver then try to calcualte correct!
«5,000 DnaNudge machines, how much the equivalent order would cost to buy the MiQLab? nearly $1billion, $95,000,000 to be exact»
So far all your posts are useless

<< Previous

Bullboard Posts

Next >>

Corus reports Q1 profit drop in the face of falling revenue